{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T08:46:38Z","timestamp":1785919598087,"version":"3.56.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010882","name":"Tianjin Municipal Education Commission","doi-asserted-by":"publisher","award":["2023YXZX17"],"award-info":[{"award-number":["2023YXZX17"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"publisher","award":["TJYXZDXK-3-032C"],"award-info":[{"award-number":["TJYXZDXK-3-032C"]}],"id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08501-7","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:34:17Z","timestamp":1781886857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bronchoalveolar lavage microbiota signatures and stage-associated alterations in early-stage and advanced-stage non-small cell lung cancer: a pilot study"],"prefix":"10.1186","volume":"24","author":[{"given":"Yajing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Bin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4854-6187","authenticated-orcid":false,"given":"Hui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"8501_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"8501_CR2","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.21037\/tlcr-22-240","volume":"11","author":"S He","year":"2022","unstructured":"He S, Li H, Cao M, Sun D, Yang F, Yan X, Zhang S, He Y, Du L, Sun X, et al. Survival of 7,311 lung cancer patients by pathological stage and histological classification: a multicenter hospital-based study in China. Transl Lung Cancer Res. 2022;11:1591\u2013605.","journal-title":"Transl Lung Cancer Res"},{"key":"8501_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P, Mitchell A, Bolejack V. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016;11:39\u201351.","journal-title":"J Thorac Oncol"},{"key":"8501_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s13054-025-05548-8","volume":"29","author":"K Schneider","year":"2025","unstructured":"Schneider K, Ulrichsen JU, Westphal AN, Iepsen UW, Ronit A, Plovsing RR, Berg RMG. Composition and diversity of the pulmonary microbiome in acute respiratory distress syndrome: a systematic review. Crit Care. 2025;29:361.","journal-title":"Crit Care"},{"key":"8501_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/2049-2618-1-19","volume":"1","author":"LN Segal","year":"2013","unstructured":"Segal LN, Alekseyenko AV, Clemente JC, Kulkarni R, Wu B, Gao Z, Chen H, Berger KI, Goldring RM, Rom WN, et al. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome. 2013;1:19.","journal-title":"Microbiome"},{"key":"8501_CR6","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3389\/fphys.2018.01168","volume":"9","author":"E Mathieu","year":"2018","unstructured":"Mathieu E, Escribano-Vazquez U, Descamps D, Cherbuy C, Langella P, Riffault S, Remot A, Thomas M. Paradigms of Lung Microbiota Functions in Health and Disease, Particularly, in Asthma. Front Physiol. 2018;9:1168.","journal-title":"Front Physiol"},{"key":"8501_CR7","first-page":"1","volume":"39","author":"V Iebba","year":"2016","unstructured":"Iebba V, Totino V, Gagliardi A, Santangelo F, Cacciotti F, Trancassini M, Mancini C, Cicerone C, Corazziari E, Pantanella F, Schippa S. Eubiosis and dysbiosis: the two sides of the microbiota. New Microbiol. 2016;39:1\u201312.","journal-title":"New Microbiol"},{"key":"8501_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13059-018-1501-6","volume":"19","author":"KL Greathouse","year":"2018","unstructured":"Greathouse KL, White JR, Vargas AJ, Bliskovsky VV, Beck JA, von Muhlinen N, Polley EC, Bowman ED, Khan MA, Robles AI, et al. Interaction between the microbiome and TP53 in human lung cancer. Genome Biol. 2018;19:123.","journal-title":"Genome Biol"},{"key":"8501_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.trecan.2019.12.007","volume":"6","author":"AG Ram\u00edrez-Labrada","year":"2020","unstructured":"Ram\u00edrez-Labrada AG, Isla D, Artal A, Arias M, Rezusta A, Pardo J, G\u00e1lvez EM. The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy. Trends Cancer. 2020;6:86\u201397.","journal-title":"Trends Cancer"},{"key":"8501_CR10","doi-asserted-by":"crossref","unstructured":"Lopez de Rodas M, Nagineni V, Ravi A, Datar IJ, Mino-Kenudson M, Corredor G, Barrera C, Behlman L, Rimm DL, Herbst RS, et al. Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer. J Immunother Cancer. 2022;10.","DOI":"10.1136\/jitc-2021-004440"},{"key":"8501_CR11","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jtho.2016.01.015","volume":"11","author":"RM Bremnes","year":"2016","unstructured":"Bremnes RM, Busund LT, Kilv\u00e6r TL, Andersen S, Richardsen E, Paulsen EE, Hald S, Khanehkenari MR, Cooper WA, Kao SC, D\u00f8nnem T. The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer. J Thorac Oncol. 2016;11:789\u2013800.","journal-title":"J Thorac Oncol"},{"key":"8501_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nri3152","volume":"12","author":"SL Swain","year":"2012","unstructured":"Swain SL, McKinstry KK, Strutt TM. Expanding roles for CD4\u207a T cells in immunity to viruses. Nat Rev Immunol. 2012;12:136\u201348.","journal-title":"Nat Rev Immunol"},{"key":"8501_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00262-009-0736-1","volume":"59","author":"N Larmonier","year":"2010","unstructured":"Larmonier N, Fraszczak J, Lakomy D, Bonnotte B, Katsanis E. Killer dendritic cells and their potential for cancer immunotherapy. Cancer Immunol Immunother. 2010;59:1\u201311.","journal-title":"Cancer Immunol Immunother"},{"key":"8501_CR14","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.cell.2024.03.021","volume":"187","author":"TW Battaglia","year":"2024","unstructured":"Battaglia TW, Mimpen IL, Traets JJH, van Hoeck A, Zeverijn LJ, Geurts BS, de Wit GF, No\u00eb M, Hofland I, Vos JL, et al. A pan-cancer analysis of the microbiome in metastatic cancer. Cell. 2024;187:2324\u2013e23352319.","journal-title":"Cell"},{"key":"8501_CR15","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s00262-020-02798-z","volume":"70","author":"P Bezel","year":"2021","unstructured":"Bezel P, Valaperti A, Steiner U, Scholtze D, Wieser S, Vonow-Eisenring M, Widmer A, Kowalski B, Kohler M, Franzen DP. Evaluation of cytokines in the tumor microenvironment of lung cancer using bronchoalveolar lavage fluid analysis. Cancer Immunol Immunother. 2021;70:1867\u201376.","journal-title":"Cancer Immunol Immunother"},{"key":"8501_CR16","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s00134-007-0689-9","volume":"33","author":"O Mimoz","year":"2007","unstructured":"Mimoz O, Dahyot-Fizelier C. Mini-broncho-alveolar lavage: a simple and promising method for assessment of antibiotic concentration in epithelial lining fluid. Intensive Care Med. 2007;33:1495\u20137.","journal-title":"Intensive Care Med"},{"key":"8501_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.lungcan.2019.08.022","volume":"136","author":"J Jin","year":"2019","unstructured":"Jin J, Gan Y, Liu H, Wang Z, Yuan J, Deng T, Zhou Y, Zhu Y, Zhu H, Yang S, et al. Diminishing microbiome richness and distinction in the lower respiratory tract of lung cancer patients: A multiple comparative study design with independent validation. Lung Cancer. 2019;136:129\u201335.","journal-title":"Lung Cancer"},{"key":"8501_CR18","doi-asserted-by":"publisher","first-page":"7298","DOI":"10.3390\/jcm11247298","volume":"11","author":"J Huang","year":"2022","unstructured":"Huang J, Huang J. Microbial Biomarkers for Lung Cancer: Current Understandings and Limitations. J Clin Med. 2022;11:7298.","journal-title":"J Clin Med"},{"key":"8501_CR19","first-page":"2047","volume":"9","author":"D Huang","year":"2019","unstructured":"Huang D, Su X, Yuan M, Zhang S, He J, Deng Q, Qiu W, Dong H, Cai S. The characterization of lung microbiome in lung cancer patients with different clinicopathology. Am J Cancer Res. 2019;9:2047\u201363.","journal-title":"Am J Cancer Res"},{"key":"8501_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000068414","volume":"70","author":"J Domaga\u0142a-Kulawik","year":"2003","unstructured":"Domaga\u0142a-Kulawik J, Guzman J, Costabel U. Immune cells in bronchoalveolar lavage in peripheral lung cancer\u2013analysis of 140 cases. Respiration. 2003;70:43\u20138.","journal-title":"Respiration"},{"key":"8501_CR21","doi-asserted-by":"publisher","first-page":"1589843","DOI":"10.3389\/fimmu.2025.1589843","volume":"16","author":"J Cheng","year":"2025","unstructured":"Cheng J, Wang H. Lung microbiome alterations correlate with immune imbalance in non-small cell lung cancer. Front Immunol. 2025;16:1589843.","journal-title":"Front Immunol"},{"key":"8501_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12931-020-01392-2","volume":"21","author":"R Bingula","year":"2020","unstructured":"Bingula R, Filaire E, Molnar I, Delmas E, Berthon JY, Vasson MP, Bernalier-Donadille A, Filaire M. Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: a cross-sectional clinical trial. Respir Res. 2020;21:129.","journal-title":"Respir Res"},{"key":"8501_CR23","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jtho.2024.02.011","volume":"19","author":"R Rami-Porta","year":"2024","unstructured":"Rami-Porta R, Nishimura KK, Giroux DJ, Detterbeck F, Cardillo G, Edwards JG, Fong KM, Giuliani M, Huang J, Kernstine KH, Sr, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2024;19:1007\u201327.","journal-title":"J Thorac Oncol"},{"key":"8501_CR24","doi-asserted-by":"crossref","unstructured":"Nagy L, Urb\u00e1n P, Makszin L, S\u00e1ndor V, Kil\u00e1r A, \u00c1brah\u00e1m H, Albert B, Kocsis B, Kil\u00e1r F. The effect of mutation in lipopolysaccharide biosynthesis on bacterial fitness. Cells. 2022;11.","DOI":"10.3390\/cells11203249"},{"key":"8501_CR25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11427-016-5029-2","volume":"59","author":"Q Fu","year":"2016","unstructured":"Fu Q, Wang W, Zhou T, Yang Y. Emerging roles of NudC family: from molecular regulation to clinical implications. Sci China Life Sci. 2016;59:455\u201362.","journal-title":"Sci China Life Sci"},{"key":"8501_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1271\/bbb.65.213","volume":"65","author":"K Takeda","year":"2001","unstructured":"Takeda K, Akimoto C, Kawamukai M. Effects of the Escherichia coli sfsA gene on mal genes expression and a DNA binding activity of SfsA. Biosci Biotechnol Biochem. 2001;65:213\u20137.","journal-title":"Biosci Biotechnol Biochem"},{"key":"8501_CR27","doi-asserted-by":"publisher","first-page":"1517959","DOI":"10.3389\/fimmu.2025.1517959","volume":"16","author":"J Yu","year":"2025","unstructured":"Yu J, Fu L, Wu R, Che L, Liu G, Ran Q, Xia Z, Liang X, Zhao G. Immunocytes in the tumor microenvironment: recent updates and interconnections. Front Immunol. 2025;16:1517959.","journal-title":"Front Immunol"},{"key":"8501_CR28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12866-023-02931-9","volume":"23","author":"S Najafi","year":"2023","unstructured":"Najafi S, Jamalkandi SA, Najafi A, Salimian J, Ahmadi A. Exploring Co-occurrence patterns and microbial diversity in the lung microbiome of patients with non-small cell lung cancer. BMC Microbiol. 2023;23:182.","journal-title":"BMC Microbiol"},{"key":"8501_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-022-01304-4","volume":"8","author":"L Yang","year":"2023","unstructured":"Yang L, Li A, Wang Y, Zhang Y. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal Transduct Target Ther. 2023;8:35.","journal-title":"Signal Transduct Target Ther"},{"key":"8501_CR30","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, Rotter-Maskowitz A, Weiser R, Mallel G, Gigi E, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368:973\u201380.","journal-title":"Science"},{"key":"8501_CR31","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1099\/ijs.0.64308-0","volume":"56","author":"D Muller","year":"2006","unstructured":"Muller D, Simeonova DD, Riegel P, Mangenot S, Koechler S, Li\u00e8vremont D, Bertin PN, Lett MC. Herminiimonas arsenicoxydans sp. nov., a metalloresistant bacterium. Int J Syst Evol Microbiol. 2006;56:1765\u20139.","journal-title":"Int J Syst Evol Microbiol"},{"key":"8501_CR32","doi-asserted-by":"publisher","first-page":"2552913","DOI":"10.1080\/0886022X.2025.2552913","volume":"47","author":"L Lu","year":"2025","unstructured":"Lu L, Li Y, Zhou Y, Chen J, Fu T, Zhuang J, Peng H, Liu F, Sun L, Lu J, Xiong G. Triptolide improves microbial dysbiosis and metabolite disorder in db\/db mice. Ren Fail. 2025;47:2552913.","journal-title":"Ren Fail"},{"key":"8501_CR33","doi-asserted-by":"publisher","first-page":"155774","DOI":"10.1016\/j.phymed.2024.155774","volume":"130","author":"D Liu","year":"2024","unstructured":"Liu D, Zhan J, Wang S, Chen L, Zhu Q, Nie R, Zhou X, Zheng W, Luo X, Wang B, et al. Chrysanthemum morifolium attenuates metabolic and alcohol-associated liver disease via gut microbiota and PPAR\u03b1\/\u03b3 activation. Phytomedicine. 2024;130:155774.","journal-title":"Phytomedicine"},{"key":"8501_CR34","doi-asserted-by":"publisher","first-page":"118445","DOI":"10.1016\/j.jep.2024.118445","volume":"333","author":"S Liu","year":"2024","unstructured":"Liu S, Zhang Q, Zhao F, Deng F, Wang Y. Regulating effect of Qifu Yin on intestinal microbiota in mice with memory impairment induced by scopolamine hydrobromide. J Ethnopharmacol. 2024;333:118445.","journal-title":"J Ethnopharmacol"},{"key":"8501_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.lungcan.2016.10.016","volume":"102","author":"SH Lee","year":"2016","unstructured":"Lee SH, Sung JY, Yong D, Chun J, Kim SY, Song JH, Chung KS, Kim EY, Jung JY, Kang YA, et al. Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions. Lung Cancer. 2016;102:89\u201395.","journal-title":"Lung Cancer"},{"key":"8501_CR36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1158\/2159-8290.CD-20-0263","volume":"11","author":"JJ Tsay","year":"2021","unstructured":"Tsay JJ, Wu BG, Sulaiman I, Gershner K, Schluger R, Li Y, Yie TA, Meyn P, Olsen E, Perez L, et al. Lower Airway Dysbiosis Affects Lung Cancer Progression. Cancer Discov. 2021;11:293\u2013307.","journal-title":"Cancer Discov"},{"key":"8501_CR37","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1164\/rccm.201710-2118OC","volume":"198","author":"JJ Tsay","year":"2018","unstructured":"Tsay JJ, Wu BG, Badri MH, Clemente JC, Shen N, Meyn P, Li Y, Yie TA, Lhakhang T, Olsen E, et al. Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer. Am J Respir Crit Care Med. 2018;198:1188\u201398.","journal-title":"Am J Respir Crit Care Med"},{"key":"8501_CR38","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","volume":"176","author":"C Jin","year":"2019","unstructured":"Jin C, Lagoudas GK, Zhao C, Bullman S, Bhutkar A, Hu B, Ameh S, Sandel D, Liang XS, Mazzilli S, et al. Commensal Microbiota Promote Lung Cancer Development via \u03b3\u03b4 T Cells. Cell. 2019;176:998\u2013e10131016.","journal-title":"Cell"},{"key":"8501_CR39","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/ijc.31098","volume":"142","author":"HX Liu","year":"2018","unstructured":"Liu HX, Tao LL, Zhang J, Zhu YG, Zheng Y, Liu D, Zhou M, Ke H, Shi MM, Qu JM. Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects. Int J Cancer. 2018;142:769\u201378.","journal-title":"Int J Cancer"},{"key":"8501_CR40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12943-022-01544-6","volume":"21","author":"EA Marshall","year":"2022","unstructured":"Marshall EA, Filho FSL, Sin DD, Lam S, Leung JM, Lam WL. Distinct bronchial microbiome precedes clinical diagnosis of lung cancer. Mol Cancer. 2022;21:68.","journal-title":"Mol Cancer"},{"key":"8501_CR41","doi-asserted-by":"publisher","first-page":"7127","DOI":"10.1002\/cam4.5513","volume":"12","author":"Q Chen","year":"2023","unstructured":"Chen Q, Hou K, Tang M, Ying S, Zhao X, Li G, Pan J, He X, Xia H, Li Y, et al. Screening of potential microbial markers for lung cancer using metagenomic sequencing. Cancer Med. 2023;12:7127\u201339.","journal-title":"Cancer Med"},{"key":"8501_CR42","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1158\/1055-9965.EPI-18-0966","volume":"28","author":"BA Peters","year":"2019","unstructured":"Peters BA, Hayes RB, Goparaju C, Reid C, Pass HI, Ahn J. The Microbiome in Lung Cancer Tissue and Recurrence-Free Survival. Cancer Epidemiol Biomarkers Prev. 2019;28:731\u201340.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"8501_CR43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13073-022-01126-7","volume":"14","author":"BA Peters","year":"2022","unstructured":"Peters BA, Pass HI, Burk RD, Xue X, Goparaju C, Sollecito CC, Grassi E, Segal LN, Tsay JJ, Hayes RB, Ahn J. The lung microbiome, peripheral gene expression, and recurrence-free survival after resection of stage II non-small cell lung cancer. Genome Med. 2022;14:121.","journal-title":"Genome Med"},{"key":"8501_CR44","doi-asserted-by":"publisher","first-page":"693","DOI":"10.21037\/tlcr-19-590","volume":"9","author":"C Cheng","year":"2020","unstructured":"Cheng C, Wang Z, Wang J, Ding C, Sun C, Liu P, Xu X, Liu Y, Chen B, Gu B. Characterization of the lung microbiome and exploration of potential bacterial biomarkers for lung cancer. Transl Lung Cancer Res. 2020;9:693\u2013704.","journal-title":"Transl Lung Cancer Res"},{"key":"8501_CR45","doi-asserted-by":"publisher","first-page":"e947","DOI":"10.1002\/ctm2.947","volume":"12","author":"X Qian","year":"2022","unstructured":"Qian X, Zhang HY, Li QL, Ma GJ, Chen Z, Ji XM, Li CY, Zhang AQ. Integrated microbiome, metabolome, and proteome analysis identifies a novel interplay among commensal bacteria, metabolites and candidate targets in non-small cell lung cancer. Clin Transl Med. 2022;12:e947.","journal-title":"Clin Transl Med"},{"key":"8501_CR46","doi-asserted-by":"publisher","first-page":"1261284","DOI":"10.3389\/fcimb.2023.1261284","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen X, Wang Y, Li L, Ju Q, Zhang Y, Xi H, Wang F, Qiu D, Liu X, et al. Alterations of lower respiratory tract microbiome and short-chain fatty acids in different segments in lung cancer: a multiomics analysis. Front Cell Infect Microbiol. 2023;13:1261284.","journal-title":"Front Cell Infect Microbiol"},{"key":"8501_CR47","doi-asserted-by":"publisher","first-page":"e0080221","DOI":"10.1128\/Spectrum.00802-21","volume":"9","author":"H Lu","year":"2021","unstructured":"Lu H, Gao NL, Tong F, Wang J, Li H, Zhang R, Ma H, Yang N, Zhang Y, Wang Y, et al. Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis. Microbiol Spectr. 2021;9:e0080221.","journal-title":"Microbiol Spectr"},{"key":"8501_CR48","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1186\/s12967-024-05485-0","volume":"22","author":"Y Sun","year":"2024","unstructured":"Sun Y, Gan Z, Wang X, Liu J, Zhong W, Zhang Z, Zuo J, Zhong H, Huang X, Yan Z, Cao Q. Integrative metagenomic, transcriptomic, and proteomic analysis reveal the microbiota-host interplay in early-stage lung adenocarcinoma among non-smokers. J Transl Med. 2024;22:652.","journal-title":"J Transl Med"},{"key":"8501_CR49","doi-asserted-by":"crossref","unstructured":"Mariniello A, Tabb\u00f2 F, Indellicati D, Tesauro M, Rezmives NA, Reale ML, List\u00ec A, Capelletto E, Carnio S, Bertaglia V, et al. Comparing T cell subsets in Broncho-Alveolar Lavage (BAL) and peripheral blood in patients with advanced lung cancer. Cells. 2022;11.","DOI":"10.3390\/cells11203226"},{"key":"8501_CR50","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/dc.2040","volume":"25","author":"J Domaga\u0142a-Kulawik","year":"2001","unstructured":"Domaga\u0142a-Kulawik J, Hoser G, Droszcz P, Kawiak J, Droszcz W, Chazan R. T-cell subtypes in bronchoalveolar lavage fluid and in peripheral blood from patients with primary lung cancer. Diagn Cytopathol. 2001;25:208\u201313.","journal-title":"Diagn Cytopathol"},{"key":"8501_CR51","doi-asserted-by":"publisher","first-page":"1868122","DOI":"10.1080\/2162402X.2020.1868122","volume":"10","author":"Q Li","year":"2021","unstructured":"Li Q, Li Y, Wang Y, Xu L, Guo Y, Wang Y, Wang L, Guo C. Oral administration of Bifidobacterium breve promotes antitumor efficacy via dendritic cells-derived interleukin 12. Oncoimmunology. 2021;10:1868122.","journal-title":"Oncoimmunology"},{"key":"8501_CR52","doi-asserted-by":"publisher","first-page":"111542","DOI":"10.1016\/j.biopha.2021.111542","volume":"140","author":"G Chen","year":"2021","unstructured":"Chen G, Cao Z, Shi Z, Lei H, Chen C, Yuan P, Wu F, Liu C, Dong M, Song Y, et al. Microbiome analysis combined with targeted metabolomics reveal immunological anti-tumor activity of icariside I in a melanoma mouse model. Biomed Pharmacother. 2021;140:111542.","journal-title":"Biomed Pharmacother"},{"key":"8501_CR53","doi-asserted-by":"publisher","first-page":"116132","DOI":"10.1016\/j.celrep.2025.116132","volume":"44","author":"Q Song","year":"2025","unstructured":"Song Q, Li X, Li Q, Shang S, Ma S, Zhai Z, Sun F, Mo Y, Wei L, Wu M, et al. Bifidobacterium animalis suppresses non-small cell lung cancer progression and modulates tumor immunity through indole-3-acetic acid. Cell Rep. 2025;44:116132.","journal-title":"Cell Rep"},{"key":"8501_CR54","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.abc3421","volume":"369","author":"LF Mager","year":"2020","unstructured":"Mager LF, Burkhard R, Pett N, Cooke NCA, Brown K, Ramay H, Paik S, Stagg J, Groves RA, Gallo M, et al. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science. 2020;369:1481\u20139.","journal-title":"Science"},{"key":"8501_CR55","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B, Alegre ML, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015;350:1084\u20139.","journal-title":"Science"},{"key":"8501_CR56","doi-asserted-by":"publisher","first-page":"1669172","DOI":"10.3389\/fmicb.2025.1669172","volume":"16","author":"J Wang","year":"2025","unstructured":"Wang J, Su W, Chen Q, Zhou J, Wang X, Jiang R, Li J, Xing P. Microbiome-metabolome dysbiosis of bronchoalveolar lavage fluid of lung cancer patients. Front Microbiol. 2025;16:1669172.","journal-title":"Front Microbiol"},{"key":"8501_CR57","doi-asserted-by":"publisher","first-page":"1390722","DOI":"10.3389\/fmicb.2024.1390722","volume":"15","author":"Z Chen","year":"2024","unstructured":"Chen Z, Wang Z, Ma H, Bao H, Jiang T, Yang T, Ma S. Immune cells mediated the causal relationship between the gut microbiota and lung cancer: a Mendelian randomization study. Front Microbiol. 2024;15:1390722.","journal-title":"Front Microbiol"},{"key":"8501_CR58","doi-asserted-by":"publisher","first-page":"109496","DOI":"10.1016\/j.cbi.2021.109496","volume":"344","author":"Z Qu","year":"2021","unstructured":"Qu Z, Zhang L, Hou R, Ma X, Yu J, Zhang W, Zhuang C. Exposure to a mixture of cigarette smoke carcinogens disturbs gut microbiota and influences metabolic homeostasis in A\/J mice. Chem Biol Interact. 2021;344:109496.","journal-title":"Chem Biol Interact"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08501-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08501-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08501-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T08:03:27Z","timestamp":1785917007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08501-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8501"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08501-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Tianjin Chest Hospital (No. 2024-KY-019-01) and carried out only after written informed consent had been obtained from each participant.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors do not have conflicts of interest to declare.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"999"}}